(UPDATE – 30 May / 5:24 PM): The government has since backtracked and decided not to roll out this feature. More details right here.
(ORIGINAL STORY – 27 May / 5:35 PM):
The coordinator of the National COVID-19 Immunisation Programme (PICK), Minister Khairy Jamaluddin today has announced that the public can soon choose their own preferred brand of COVID-19 vaccine.
This ability will be delivered through an upcoming update to the national COVID-19 app, MySejahtera. However, Minister Khairy didn’t reveal when exactly the update will be rolled out to users as the authorities are still working out the details.
Tahukah anda jenis-jenis vaksin COVID-19 yang akan digunakan di Malaysia? Ikuti carta di bawah untuk info ringkas berkenaan vaksin-vaksin ini.
Muat turun aplikasi MySejahtera untuk info pendaftaran vaksinasi: https://t.co/cHy3gwpup2 #LindungDiriLindungSemua pic.twitter.com/UQuXQXoujY
— Vaksin COVID-19 🇲🇾 (@JKJAVMY) February 13, 2021
He pointed out factors pertaining to the update that his team are currently looking at on how people can choose the appointment which covers the date, location, and the preferred vaccine. The minister further added that the main objective is to make the process as easy as possible.
Furthermore, this would encourage the public to use the app more often. Minister Khairy also said that the announcement regarding this new approach is expected to take place within the next few weeks.
At the same time, he has also announced that the AstraZeneca (AZ) vaccine will be placed back into the main PICK rollout. This means that the vaccine will not be offered through a separate registration session as per what has been done on 2 May as well as between 23 to 26 May.
In general, these sessions have shown that the public is now willing to accept the vaccine. Additionally, the authorities are also now hoping that they will no longer have to face the barrage of complaints following the massive amount of technical problems and horrible user experience that popped up during these sessions.
(Source: MOSTI / Facebook.)
